GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
10.50
-0.05 (-0.47%)
Mar 7, 2025, 4:00 PM EST - Market closed
GH Research Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 15.3 | 11.4 | 10.07 | 6.55 | 0.11 | |
| Research & Development | 35.02 | 29.82 | 20.48 | 8.55 | 0.34 | |
| Operating Expenses | 50.25 | 41.22 | 30.68 | 15.1 | 0.45 | |
| Operating Income | -50.25 | -41.22 | -30.68 | -15.1 | -0.45 | |
| Interest Expense | -0.72 | -0.72 | -0.12 | -0.01 | - | |
| Interest & Investment Income | 6.28 | 6.03 | 0.86 | - | - | |
| Currency Exchange Gain (Loss) | 2.13 | -2.62 | 7.18 | 5.91 | - | |
| EBT Excluding Unusual Items | -42.56 | -38.54 | -22.76 | -9.2 | -0.45 | |
| Gain (Loss) on Sale of Investments | 3.6 | 2.95 | 0.31 | - | - | |
| Pretax Income | -38.96 | -35.59 | -22.46 | -9.2 | -0.45 | |
| Net Income | -38.96 | -35.59 | -22.46 | -9.2 | -0.45 | |
| Net Income to Common | -38.96 | -35.59 | -22.46 | -9.2 | -0.45 | |
| Shares Outstanding (Basic) | 52 | 52 | 52 | 44 | 28 | |
| Shares Outstanding (Diluted) | 52 | 52 | 52 | 44 | 28 | |
| Shares Change (YoY) | 0.01% | 0.00% | 19.09% | 54.03% | 1.28% | |
| EPS (Basic) | -0.75 | -0.68 | -0.43 | -0.21 | -0.02 | |
| EPS (Diluted) | -0.75 | -0.68 | -0.43 | -0.21 | -0.02 | |
| Free Cash Flow | -42.33 | -33.44 | -26.27 | -15.39 | -0.33 | |
| Free Cash Flow Per Share | -0.81 | -0.64 | -0.50 | -0.35 | -0.01 | |
| EBITDA | -50.18 | -41.15 | -30.63 | -15.08 | - | |
| D&A For EBITDA | 0.07 | 0.07 | 0.05 | 0.02 | - | |
| EBIT | -50.25 | -41.22 | -30.68 | -15.1 | -0.45 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.